Results 241 to 250 of about 1,603,308 (337)

The First‐in‐Man Technique of Drug Eluting and Perfusion Therapy for Left Main Coronary Artery Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Treating ostial left circumflex artery (LCx) lesions in percutaneous coronary intervention (PCI) for left main disease (LMD) remains a challenge. Despite recent recommendations for the use of drug‐coated balloon (DCB) in this lesion, there are concerns about crossover‐stenting from the left main trunk (LMT) to the left anterior ...
Takayuki Warisawa, Yoshiki Kawai, Takuya Matsumoto, Shingo Sato, Makoto Takeyama, Yuta Nakamura, Susumu Katsushika, Aritomo Katsura, Takahiro Sato, Masashiro Matsushita, Jiro Ando   +10 more
wiley   +1 more source

Family-based substance use screening and intervention for adolescents with chronic medical conditions: a study protocol to implement SBIRT-family within school-based health centers. [PDF]

Front Health Serv
Summersett Williams F, Larez NA, Mondesir L, Curtis K, Valdivia S, Becker S, Papineau K, Hogue A.   +7 more
europepmc   +1 more source

A Six‐Step Approach for Optimizing Ultrasound‐Guided Femoral Artery Access

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Femoral arterial access is fundamental to interventional cardiology, especially for complex procedures that require large‐bore devices. However, vascular complications arising from suboptimal puncture techniques highlight the need for meticulous practice.
Fernando Luiz de Melo Bernardi, Guilherme Luiz de Melo Bernardi, Júlio Roberto Barbiero, Adalberto Gloeckner de Meira, Luiz Felipe Monsanto Fernandes Alves, Dinaldo Cavalcanti de Oliveira, Estevão Carvalho de Campos Martins   +6 more
wiley   +1 more source

Electrocardiographic R Wave Peak Time: Correlation With the Severity of Coronary Artery Disease and Prognosis in Patients With Acute Coronary Syndrome

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Electrocardiographic parameters have emerged as valuable noninvasive markers for risk stratification in acute coronary syndrome (ACS). Aims This study aimed to evaluate the correlation between R wave peak time (RWPT) and coronary artery disease (CAD) severity, and to assess its prognostic value for in‐hospital major adverse cardiac ...
Jilin Xu, Wen Yu, Xiuqi Li, Xingan Wu, Baozhen Tan, Jing Han   +5 more
wiley   +1 more source

Global perspectives on challenges, coping strategies, and future preparedness of nursing home staff during COVID-19: a systematic review and meta-synthesis. [PDF]

BMC Health Serv Res
Yang XF, Guo JY, Peng WS, Wang BD, Qv CR, Zhou SJ, Sun R, Liao L, Zhang WW, Liu LY, Ren LC, Zou L, Xu SH.   +12 more
europepmc   +1 more source

An Euroheart‐Based Percutaneous Coronary Intervention Registry in Vietnam: Design, Rationale, and Preliminary Results

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background As a cardiac interventional procedure, percutaneous coronary intervention (PCI) is increasingly becoming the most widely adopted across the globe. With increasing implementation in practice, the use of PCI registries to evaluate safety and effectiveness has grown internationally.
Vu Hoang Vu, Khang Duong Nguyen, Bao Thien Duong, Ngoc Minh Pham, Christopher M. Reid, Binh Quang Truong, Richard Norman   +6 more
wiley   +1 more source

Providing medicines-related support for people with COPD before and after hospital discharge-a qualitative study of hospital staff perspectives. [PDF]

BMC Health Serv Res
Nygård T, Wright D, Kjome RLS, Nazar H, Raddum A.   +4 more
europepmc   +1 more source

Allied health professionals' experiences of co-worker unprofessional behaviour and their reported speaking-up skills: A secondary analysis of a cross-sectional survey. [PDF]

Future Healthc J
McMullan RD, Badgery-Parker T, Li L, Urwin R, Westbrook JI.   +4 more
europepmc   +1 more source

Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open‐Label, Phase I Study

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Valemetostat tosylate (valemetostat) is a dual inhibitor of enhancer of zeste homolog (EZH) 2 and EZH1, approved in Japan for the treatment of relapsed/refractory peripheral T‐cell lymphoma and adult T‐cell leukemia/lymphoma. This Phase I, open‐label study evaluated the pharmacokinetics and safety of a single 50‐mg oral dose of valemetostat in
Masaya Tachibana, Thuy Vu Craveiro, Thomas C. Marbury, Samuel Oberstein, George J. Atiee, Ben Tao, Takako Shimizu, Yvonne Lau, Malaz A. Abutarif   +8 more
wiley   +1 more source

Oops!…I Did it Again, I Gave You Some Carbs: Prescribing Errors in Inpatient Ketogenic Diet Management. [PDF]

Epilepsy Curr
Cervenka MC.
europepmc   +1 more source